Current role
James Loerop
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Loerop
The proxy statement of Aclaris Therapeutics, Inc. reports total compensation of $1,447,106 for James Loerop in fiscal 2025, including a base salary of $416,000. Disclosed compensation is on record for 7 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Aclaris Therapeutics, Inc. (ACRS)
Proxy statement
CurrentStart not stated–present
-
Anika Therapeutics, Inc. (ANIK)
Proxy statement
Start not stated–2021-04-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aclaris Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Neal Walker CEO, Chairman, Board Member
- Kevin Balthaser CFO
- Douglas Manion COO, Board Member
- Douglas Manion, M.D., FRCP (C) COO
- Hugh Davis COO, Board Member
- Andrew Schiff, M.D. Board Member
- Vincent Milano Board Member
- William Humphries Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aclaris Therapeutics, Inc. (ACRS) | Chief Business Officer | $416,000 | $1,447,106 |
| 2023 | Aclaris Therapeutics, Inc. (ACRS) | Chief Business Officer | $435,000 | $2,332,912 |
| 2022 | Anika Therapeutics, Inc. (ANIK) | former EVP, Business Development and | $36,454 | $73,617 |
| 2021 | Anika Therapeutics, Inc. (ANIK) | former EVP, Business Development and | $394,900 | $874,404 |
| 2020 | Anika Therapeutics, Inc. (ANIK) | EVP, Business Development and Strategic Planning | $381,563 | $1,039,871 |
| 2019 | Anika Therapeutics, Inc. (ANIK) | EVP, Business Development and Strategic Planning | $165,865 | $1,479,626 |
| 2018 | Anika Therapeutics, Inc. (ANIK) | EVP, Business Development and Strategic Planning | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.